IL220164B - A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix - Google Patents

A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix

Info

Publication number
IL220164B
IL220164B IL220164A IL22016412A IL220164B IL 220164 B IL220164 B IL 220164B IL 220164 A IL220164 A IL 220164A IL 22016412 A IL22016412 A IL 22016412A IL 220164 B IL220164 B IL 220164B
Authority
IL
Israel
Prior art keywords
fusion protein
antibody
affinity chromatography
chromatography matrix
producing purified
Prior art date
Application number
IL220164A
Other languages
English (en)
Hebrew (he)
Other versions
IL220164A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43598315&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL220164(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL220164A0 publication Critical patent/IL220164A0/en
Publication of IL220164B publication Critical patent/IL220164B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL220164A 2009-12-18 2012-06-04 A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix IL220164B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28805909P 2009-12-18 2009-12-18
PCT/EP2010/070076 WO2011073389A1 (en) 2009-12-18 2010-12-17 Wash solution and method for affinity chromatography

Publications (2)

Publication Number Publication Date
IL220164A0 IL220164A0 (en) 2012-07-31
IL220164B true IL220164B (en) 2019-02-28

Family

ID=43598315

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220164A IL220164B (en) 2009-12-18 2012-06-04 A method for purifying a purified antibody, antibody fragment, or fc-fused protein using an affinity chromatography matrix

Country Status (18)

Country Link
US (3) US9505803B2 (enExample)
EP (2) EP2513134B1 (enExample)
JP (2) JP5909450B2 (enExample)
KR (1) KR101858266B1 (enExample)
CN (1) CN102725304B (enExample)
AU (1) AU2010332778B2 (enExample)
BR (1) BR112012014937B1 (enExample)
CA (1) CA2784278C (enExample)
DK (2) DK3272764T3 (enExample)
ES (2) ES2651065T3 (enExample)
IL (1) IL220164B (enExample)
LT (2) LT2513134T (enExample)
MX (1) MX2012007103A (enExample)
PL (2) PL2513134T3 (enExample)
PT (2) PT2513134T (enExample)
RU (1) RU2564569C2 (enExample)
SG (2) SG181771A1 (enExample)
WO (1) WO2011073389A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX353340B (es) 2006-09-13 2018-01-09 Abbvie Inc Mejoras de cultivos celulares.
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
TW201024318A (en) * 2008-10-20 2010-07-01 Abbott Lab Isolation and purification of antibodies using protein A affinity chromatography
SG195577A1 (en) 2008-10-20 2013-12-30 Abbott Lab Viral inactivation during purification of antibodies
DK3272764T3 (da) 2009-12-18 2024-05-06 Novartis Ag Fremgangsmåde til affinitetskromatografi
KR101753569B1 (ko) * 2010-01-22 2017-07-04 베링거 인겔하임 인터내셔날 게엠베하 Ｆｃ―함유 단백질을 정제하는 크로마토그래피 방법
ES2688348T3 (es) * 2011-06-01 2018-11-02 Novartis Ag Solución y método de lavado para cromatografía de afinidad
HRP20240230T1 (hr) 2011-10-11 2024-04-26 F. Hoffmann - La Roche Ag Poboljšani sklop bispecifičnih protutijela
JP2016519145A (ja) * 2013-05-15 2016-06-30 メディミューン リミテッド 組換え産生ポリペプチドの精製
JP6602765B2 (ja) * 2013-09-05 2019-11-06 ジェネンテック， インコーポレイテッド クロマトグラフィー再使用のための方法
CN105407905B (zh) 2014-01-03 2020-03-03 生物辐射实验室股份有限公司 蛋白a洗脱产物中杂质的去除
US11566082B2 (en) 2014-11-17 2023-01-31 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
EP3268100A1 (en) 2015-03-13 2018-01-17 Bristol-Myers Squibb Company Use of alkaline washes during chromatography to remove impurities
WO2017032610A1 (en) * 2015-08-21 2017-03-02 F. Hoffmann-La Roche Ag Affinity chromatography purification with low conductivity wash buffer
ES2877532T3 (es) 2015-08-21 2021-11-17 Hoffmann La Roche Procedimiento para la reducción de proteínas de célula huésped en cromatografía de afinidad
ES2874974T3 (es) 2016-05-11 2021-11-05 Cytiva Bioprocess R & D Ab Matriz de separación
US10730908B2 (en) 2016-05-11 2020-08-04 Ge Healthcare Bioprocess R&D Ab Separation method
JP7031934B2 (ja) 2016-05-11 2022-03-08 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックス
US10703774B2 (en) 2016-09-30 2020-07-07 Ge Healthcare Bioprocess R&D Ab Separation method
US10654887B2 (en) 2016-05-11 2020-05-19 Ge Healthcare Bio-Process R&D Ab Separation matrix
US10889615B2 (en) 2016-05-11 2021-01-12 Cytiva Bioprocess R&D Ab Mutated immunoglobulin-binding polypeptides
ES2909833T3 (es) 2016-05-11 2022-05-10 Cytiva Bioprocess R & D Ab Método de limpieza y/o desinfección de una matriz de separación
JP7106187B2 (ja) 2016-05-11 2022-07-26 サイティバ・バイオプロセス・アールアンドディ・アクチボラグ 分離マトリックスを保存する方法
US10688412B2 (en) * 2016-07-25 2020-06-23 Cehpalon, Inc. Affinity chromatography wash buffer
US12448411B2 (en) 2016-09-30 2025-10-21 Cytiva Bioprocess R&D Ab Separation method
ES2887046T3 (es) 2017-08-17 2021-12-21 Just Evotec Biologics Inc Método de purificación de proteína glicosilada a partir de galectinas de las células hospedadoras y otros contaminantes
CN107793469B (zh) * 2017-10-16 2021-07-30 上海药明生物技术有限公司 一种去除宿主细胞蛋白含量的亲和纯化工艺
JP7786876B2 (ja) 2017-12-21 2025-12-16 ジェンザイム・コーポレーション プロテインａクロマトグラフィー中の不純物の除去を促進する方法
WO2019183334A1 (en) 2018-03-21 2019-09-26 Waters Technologies Corporation Non-antibody high-affinity-based sample preparation, sorbents, devices and methods
EP3774881A1 (en) 2018-04-02 2021-02-17 Amgen Inc. Erenumab compositions and uses thereof
US11612885B2 (en) * 2018-05-08 2023-03-28 Waters Technologies Corporation Methods, compositions and kits useful for pH gradient cation exchange chromatography
KR102893280B1 (ko) * 2018-08-14 2025-12-01 브리스톨-마이어스 스큅 컴퍼니 개선된 단백질 회수
US20230399358A1 (en) * 2019-10-08 2023-12-14 North Carolina State University Immunoglobulin purification peptides and their use
US20240262928A1 (en) * 2020-03-27 2024-08-08 Haemalogix Pty Ltd Composition and Method
WO2021222120A1 (en) * 2020-04-27 2021-11-04 Alexion Pharmaceuticals, Inc. Protein a chromatography purification of an antibody
CN112827217A (zh) * 2020-12-29 2021-05-25 苏州良辰生物医药科技有限公司 一种层析柱清洗液及其应用
AU2023394724A1 (en) * 2022-12-12 2025-07-31 H. Lundbeck A/S Arginine wash in protein purification
WO2024233992A2 (en) * 2023-05-11 2024-11-14 Trophogen, Inc. Methods of manufacturing highly glycosylated glycoprotein hormones and their analogs
EP4729534A1 (en) 2024-10-21 2026-04-22 Technische Universität München, in Vertretung des Freistaats Bayern Polypeptides comprising protein domains linked via rigid amino acid linkers

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704366A (en) 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4857320A (en) * 1987-02-19 1989-08-15 Monsanto Company Method of enhancing the solubility of tissue plasminogen activator
JPH01238534A (ja) * 1988-03-17 1989-09-22 Mitsui Toatsu Chem Inc エンドトキシンの除去方法
US5429746A (en) 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
ES2337091T3 (es) 1996-11-27 2010-04-20 Genentech, Inc. Purificacion por afinidad de polipeptido en una matriz de proteina.
BRPI9910332B8 (pt) 1998-05-06 2021-05-25 Genentech Inc método para purificação de um polipeptídio a partir de uma composição
EP1084136B1 (en) 1998-06-01 2004-08-25 Genentech, Inc. Separation of antibody monomers from its multimers by use of ion-exchange chromatography
EP3088412B1 (en) 2001-03-09 2021-05-05 Chugai Seiyaku Kabushiki Kaisha Protein purification method
ES2266535T3 (es) 2001-06-05 2007-03-01 Genetics Institute, Llc Procedimientos relativos a la purificacion de proteinas altamente anionicas.
CA2473144C (en) 2002-02-05 2013-05-28 Genentech, Inc. Protein purification
ES2626268T3 (es) 2002-09-11 2017-07-24 Chugai Seiyaku Kabushiki Kaisha Método de purificación de proteínas
JP2006514100A (ja) * 2002-10-24 2006-04-27 イーノス・ファーマシューティカルス・インコーポレーテッド 徐放性ｌ−アルギニン製剤並びに製造方法および使用方法
EP1575516B1 (en) * 2002-11-26 2012-05-30 Abbott Biotherapeutics Corp. Chimeric and humanized antibodies to alpha5 beta1 integrin that modulate angiogenesis
DK1599222T3 (da) * 2003-01-08 2009-04-27 Novartis Vaccines & Diagnostic Stabiliserede vandige pr parater omfattende v vsfaktorvej-inhibitor (TFPI) eller v vsfaktorvej-inhibitorvariant
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
CA2516518A1 (en) 2003-02-28 2004-09-10 Lonza Biologics Plc. Antibody purification by protein a and ion exchange chromatography
RU2409591C2 (ru) 2003-10-27 2011-01-20 Вайет Удаление агрегатов с высокой молекулярной массой путем хроматографии на гидроксиапатитах
US8084032B2 (en) 2004-01-21 2011-12-27 Ajinomoto Co., Inc. Purification method which prevents denaturation of an antibody
EP1698637B1 (en) 2005-03-03 2008-10-15 Ajinomoto Co., Inc. A method for improving recovery yield in protein purification with gel filtration chromatography using arginine
DK1869065T3 (da) 2005-03-11 2020-06-08 Wyeth Llc Fremgangsmåde til kromatografi med svag opdeling
CN101365948B (zh) 2006-01-06 2012-11-07 Emd密理博公司 亲和层析基质及其制备和使用方法
US8263750B2 (en) 2006-03-16 2012-09-11 Amgen Inc. Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step
EP2001898A1 (en) 2006-03-20 2008-12-17 Medarex Inc. Protein purification
MX2008015263A (es) * 2006-06-02 2008-12-17 Wyeth Corp Uso de proteinas y pepetidos de la superfamilia del factor beta transformador de crecimiento para purificacion y metodos terapeuticos.
US7754689B2 (en) 2006-06-02 2010-07-13 Wyeth Llc Finger-1 peptide analogs of the TGF-β superfamily
US8513393B2 (en) 2006-08-28 2013-08-20 Ares Trading S.A. Process for the purification of Fc-containing proteins
AR062711A1 (es) * 2006-09-08 2008-11-26 Wyeth Corp Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
JP2010516651A (ja) 2007-01-17 2010-05-20 メルク セローノ ソシエテ アノニム Ｆｃ含有タンパク質の精製のための方法
MX2009012786A (es) 2007-06-01 2009-12-10 Hoffmann La Roche Purificacion de inmunoglobulina.
EP2281000A2 (en) 2008-05-15 2011-02-09 Novo Nordisk A/S Antibody purification process
WO2010019493A1 (en) 2008-08-14 2010-02-18 Merck Sharp & Dohme Corp. Methods for purifying antibodies using protein a affinity chromatography
DK3272764T3 (da) 2009-12-18 2024-05-06 Novartis Ag Fremgangsmåde til affinitetskromatografi
ES2688348T3 (es) 2011-06-01 2018-11-02 Novartis Ag Solución y método de lavado para cromatografía de afinidad

Also Published As

Publication number Publication date
EP2513134B1 (en) 2017-09-06
EP2513134A1 (en) 2012-10-24
LT2513134T (lt) 2017-11-27
US20170044211A1 (en) 2017-02-16
WO2011073389A1 (en) 2011-06-23
SG181771A1 (en) 2012-07-30
PL3272764T3 (pl) 2024-06-10
IL220164A0 (en) 2012-07-31
AU2010332778A1 (en) 2012-07-19
BR112012014937B1 (pt) 2021-01-19
CN102725304A (zh) 2012-10-10
JP5909450B2 (ja) 2016-04-26
RU2012130151A (ru) 2014-01-27
JP2016128495A (ja) 2016-07-14
US20190233469A1 (en) 2019-08-01
EP3272764A1 (en) 2018-01-24
PT2513134T (pt) 2017-12-14
PT3272764T (pt) 2024-04-24
AU2010332778B2 (en) 2015-03-19
PL2513134T3 (pl) 2018-02-28
DK3272764T3 (da) 2024-05-06
DK2513134T3 (en) 2017-12-18
RU2564569C2 (ru) 2015-10-10
US20120283416A1 (en) 2012-11-08
US9505803B2 (en) 2016-11-29
ES2982297T3 (es) 2024-10-15
BR112012014937A2 (pt) 2016-03-08
EP3272764B1 (en) 2024-02-07
MX2012007103A (es) 2012-07-17
CA2784278A1 (en) 2011-06-23
ES2651065T3 (es) 2018-01-24
LT3272764T (lt) 2024-05-10
CN102725304B (zh) 2015-12-09
KR101858266B1 (ko) 2018-05-15
KR20120109506A (ko) 2012-10-08
JP2013514073A (ja) 2013-04-25
SG10201408384PA (en) 2015-01-29
CA2784278C (en) 2019-02-26

Similar Documents

Publication Publication Date Title
AU2009282234A8 (en) Methods for purifying antibodies using protein A affinity chromatography
IL244157A0 (en) Isolation and purification of antibodies using protein a affinity chromatography
ZA201202720B (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
PT3272764T (pt) Método para cromatografia de afinidade
BRPI0918947A2 (pt) proteína de fusão de anticorpo
IL202128A0 (en) Immunoglobulin fusion proteins
WO2008157378A8 (en) Rage fusion proteins
BRPI0716139A2 (pt) processo para purificaÇço de proteÍnas de fusço fc
ZA200810677B (en) Fusion proteins, uses thereof and processes for producing same
IL210175A0 (en) Fn14/trail fusion proteins
WO2010107752A3 (en) Alpha-4-beta-7 heterodimer specific antagonist antibody
WO2007137984A3 (en) Modified humanised anti-interleukin-18 antibodies
EP2304440A4 (en) NEW MONOCLONAL ANTIBODIES AGAINST HPV PROTEINS
WO2010117760A3 (en) Fusion proteins comprising canine fc portions
HUE042919T2 (hu) Genetikai immunizáció sejthez kapcsolódó antigének - például P2X7, CXCR7 vagy CXCR4 - elleni immunglobulinok elõállítására
WO2008048519A3 (en) Antibodies that bind cxcr7 epitopes
IL215538A0 (en) Antibody fusion proteins with modified fcrn binding sites
WO2009130459A3 (en) Epitopes of il-17a and il-17f and antibodies specific thereto
EP3048112A4 (en) Fc-BINDING PROTEIN, METHOD FOR PRODUCING SAID PROTEIN, AND ANTIBODY ADSORBENT USING SAID PROTEIN, AND METHODS FOR PURIFYING AND IDENTIFYING ANTIBODY USING SAID ADSORBENT
SG11201501597VA (en) Mix-mode antibody affinity separation matrix and purification method using same, and target molecule
PL2201120T3 (pl) Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
WO2011055897A3 (en) Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same
BRPI0822347A2 (pt) método de produção de proteínas ou peptídeos heterólogos.
GB0700759D0 (en) Novel fusion protein
HK1175182A (en) Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed